51
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Iron(III)5(2′-hydroxyphenyl)-3-(4-X-phenyl)pyrazolinates and their addition complexes with N, P donor ligands: synthesis, spectral and antimicrobial investigations

, &
Pages 3314-3328 | Received 16 Nov 2007, Accepted 08 Jan 2008, Published online: 13 Oct 2008
 

Abstract

Iron(III)5(2′-hydroxyphenyl)-3-(4-X-phenyl)pyrazolinates of the type (C15H12N2OX)3Fe [where X =–H,–Cl,–CH3,–OCH3] have been synthesized by reaction of anhydrous FeCl3 with the sodium salts of pyrazoline in 1 : 3 molar ratio. Their addition complexes with N and P donor ligands [2,2′-bipyridine, 1,10-phenanthroline and triphenylphosphine] were prepared in 1:1 molar ratio. These newly synthesized derivatives have been characterized using elemental analysis (C, H, N and Fe), molecular weight measurement, magnetic moment data, FAB mass, 31P NMR and Mössbauer spectral data. The complexes have been examined for crystalline/amorphous nature through XRD; all complexes are amorphous. Octahedral geometry around iron(III) confirms the presence of three bidentate pyrazoline ligands in iron(III)5(2′-hydroxyphenyl)-3-(4-X-phenyl)pyrazolinates. In addition complexes pyrazoline is monodentate. The bidentate and monodentate behavior of pyrazoline ligands was confirmed by IR spectral data. All the complexes were tested for their in-vitro antimicrobial activity. The metal complexes and their adducts exhibit better antibacterial and antifungal activity than the pyrazolines.

Acknowledgements

The authors are thankful to RSIC, CDRI, Lucknow (India), A.P.S. University, Rewa (India), SAIF, IIT, Bombay, Mumbai (India), SIF, IISC, Bangalore (India), Mahakal Institute of Pharmaceutical Studies, Ujjain (India) and Inter University Consortium for the Department of Atomic Energy Facilities (DAEF), Indore (India) for providing spectral and analytical data.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.